Ventyx Biosciences logo

Ventyx Biosciences Share Price (NASDAQ: VTYX)

$2.4

-0.05

(-2.04%)

Last updated on

Check the interactive Ventyx Biosciences Stock chart to analyse performance

Ventyx Biosciences stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.32
    Today's High:$2.45

    Day's Volatility :5.31%

  • 52 Weeks Low:$0.78
    52 Weeks High:$3.39

    52 Weeks Volatility :76.9%

Ventyx Biosciences Stock Returns

PeriodVentyx Biosciences, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
18.14%
3.6%
0.0%
6 Months
67.36%
-7.7%
0.0%
1 Year
10.55%
-12.6%
0.0%
3 Years
-89.04%
9.5%
-4.7%

Ventyx Biosciences, Inc. Key Stats

Check Ventyx Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.45
Open
$2.45
Today's High
$2.45
Today's Low
$2.32
Market Capitalization
$179.0M
Today's Volume
$479.4K
52 Week High
$3.39
52 Week Low
$0.783
Revenue TTM
$0.0
EBITDA
$-130.1M
Earnings Per Share (EPS)
$-1.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.56%

Stock Returns calculator for Ventyx Biosciences Stock including INR - Dollar returns

The Ventyx Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ventyx Biosciences investment value today

Current value as on today

₹1,15,376

Returns

₹15,376

(+15.38%)

Returns from Ventyx Biosciences Stock

₹10,092 (+10.09%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Ventyx Biosciences Stock

-76%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Ventyx Biosciences Stock from India on INDmoney has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ventyx Biosciences, Inc.

  • Name

    Holdings %

  • Point72 Asset Management, L.P.

    8.28%

  • BlackRock Inc

    6.23%

  • Vanguard Group Inc

    4.44%

  • TANG CAPITAL MANAGEMENT LLC

    4.35%

  • Marshall Wace Asset Management Ltd

    3.36%

  • Vestal Point Capital LP

    2.81%

Analyst Recommendation on Ventyx Biosciences Stock

Rating
Trend

Buy

    68%Buy

    31%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Ventyx Biosciences(by analysts ranked 0 to 5 stars)

Ventyx Biosciences Share Price Target

What analysts predicted

Upside of 379.17%

Target:

$11.50

Current:

$2.40

Ventyx Biosciences share price target is $11.50, a slight Upside of 379.17% compared to current price of $2.40 as per analysts' prediction.

Ventyx Biosciences Stock Insights

  • Price Movement

    In the last 7 days, VTYX stock has moved down by -12.0%
  • VTYX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 61.8%
  • VTYX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 200.8%

Ventyx Biosciences Technicals Summary

Sell

Neutral

Buy

Ventyx Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ventyx Biosciences, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Ventyx Biosciences, Inc. logo
-8.37%
67.36%
10.55%
-89.04%
-88.53%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for Crohn's disease. It is also developing Tamuzimod, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor that is in Phase 2a trial for patients with early Parkinson's disease and is in Phase 2 trial for patients with obesity and additional risk factors for cardiovascular disease. Ventyx Biosciences, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Organization
Ventyx Biosciences
Employees
81
CEO
Dr. Raju S. Mohan Ph.D.
Industry
Services

Key Management of Ventyx Biosciences, Inc.

NameTitle
Dr. Sheila K. Gujrathi M.D.
Executive Chairperson
Dr. Raju S. Mohan Ph.D.
Founder, CEO, President & Director
Mr. Matthew Richard Moore
Chief Operating Officer
Dr. Mark S. Forman M.D., Ph.D.
Chief Medical Officer
Mr. Roy M. Gonzales CPA, M.B.A.
Senior VP of Finance and Principal Financial & Accounting Officer
Dr. John M. Nuss Ph.D.
Chief Scientific Officer
Ms. Snehal Naik Ph.D.
Senior VP of Clinical Development
Ms. Kathy Ogilvie Ph.D.
Senior VP of Translational & Nonclinical Research
Ms. Rosa Ferrao
Senior VP of Regulatory Affairs

Important FAQs about investing in VTYX Stock from India :

What is Ventyx Biosciences share price today?

Ventyx Biosciences share price today is $2.40 as on at the close of the market. Ventyx Biosciences share today touched a day high of $2.45 and a low of $2.32.

What is the 52 week high and 52 week low for Ventyx Biosciences share?

Ventyx Biosciences share touched a 52 week high of $3.39 and a 52 week low of $0.78. Ventyx Biosciences stock price today i.e. is closed at $2.40, lower by 29.2% versus the 52 week high.

How to invest in Ventyx Biosciences Stock (VTYX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ventyx Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ventyx Biosciences Shares that will get you 0.6250 shares as per Ventyx Biosciences share price of $2.40 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ventyx Biosciences Stock (VTYX) from India?

Indian investors can start investing in Ventyx Biosciences (VTYX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Ventyx Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Ventyx Biosciences share’s latest price of $2.40 as on August 30, 2025 at 1:29 am IST, you will get 4.1667 shares of Ventyx Biosciences. Learn more about fractional shares .

What are the returns that Ventyx Biosciences has given to Indian investors in the last 5 years?

Ventyx Biosciences stock has given -88.53% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?